1. Market Research
  2. > Cancer
2 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: A Global Market Report

  • $ 4500
  • July 2014
  • 219 pages

On Aug. ##, 2011, the FDA announced that it had approved Xalkori (crizotinib) to treat patients with late-stage (locally advanced or metastatic) NSCLC who express a rearrangement of the anaplastic lymphoma kinase (ALK) gene.

  • Cancer
  • Cancer Diagnostics
  • Genomics
  • Lymphoma
  • Molecular Diagnostics

The Global Non-Invasive Prenatal Diagnostics Market

  • $ 3500
  • July 2014
  • 108 pages

lymphoma Chiu RW, Chan KC, Gao Y, et al.

  • Genomics
  • Genomics Proteomics And Enabling Technology
  • Lymphoma
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.


View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on